Pharmacogenomics
14
0
0
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 14 trials
100.0%
+13.5% vs benchmark
21%
3 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (14)
Pharmacogenomics on Individualized Precise Treatment of Patients with Depression
Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Thai Pediatric Surgical Patients
Imapct of bioMarkers on Pharmacodynamics and Bleeding Risk of Direct Oral AntiCoagulants and Ticagrelor Study II
Implementation of a Pharmacist-led Pharmacogenomic Clinical Service
Pharmacogenomic Testing in a Program of All-inclusive Care for the Elderly (PACE) Setting
Pharmacist-led Interventions to Improve Medication Use
Effect of Genetic Polymorphisms of UGT on the PKs of Indapamide in Egyptians
Impact of Biomarkers on Pharmacokinetics and Pharmacodynamics of Direct Oral Anticoagulants
Impact of Biomarkers on Pharmacokinetics and Pharmacodynamics of Ticagrelor
A Pharmacogenomics Study of Safety and Efficacy of Enalapril or Enalapril-Folic Acid Therapy in Hypertensive Patients.
A Pharmacogenomics Study of Simvastatin-Induced Adverse Drug Reaction
A Pharmacist Implemented Pharmacogenomics Service in the Program of All-inclusive Care for the Elderly
Implementation Study of Enhanced Medication Therapy Management in Primary Care Practice
Progestagen Type in Postmenopausal Hormone Therapy and Blood Gene Expression Profile